+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
From
Sickle Cell Disease (SCD) - Pipeline Insight, 2024 - Product Thumbnail Image

Sickle Cell Disease (SCD) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
Pharmaceutical Drugs Industry: Global Competitive Landscape 2021 - Product Thumbnail Image

Pharmaceutical Drugs Industry: Global Competitive Landscape 2021

  • Report
  • October 2022
  • 307 Pages
  • Global
From
Global Liposome Drug Delivery Market Analysis 2021-2031 - Product Thumbnail Image

Global Liposome Drug Delivery Market Analysis 2021-2031

  • Report
  • May 2022
  • 225 Pages
  • Global
From
From
Cytomegalovirus (CMV) Therapeutics Market 2024-2028 - Product Thumbnail Image

Cytomegalovirus (CMV) Therapeutics Market 2024-2028

  • Report
  • October 2024
  • 144 Pages
  • Global
From
Company Snapshots: US Biotechnology - Product Thumbnail Image

Company Snapshots: US Biotechnology

  • Newsletter
  • November 2024
  • 35 Pages
  • United States
From
Pulmonary Embolism Therapeutics Market - Product Thumbnail Image

Pulmonary Embolism Therapeutics Market

  • Report
  • June 2023
  • 156 Pages
  • Global
From
From
Hospital Infection Therapeutics Market 2024-2028 - Product Thumbnail Image

Hospital Infection Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 184 Pages
  • Global
From
From
Reversible Airway Diseases Treatment Global Market Report 2024 - Product Thumbnail Image

Reversible Airway Diseases Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Loading Indicator